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To examine whether long-chain omega-3 polyunsaturated fatty acid (LCn3PUFA) levels
modify the potential neurotoxic effects of particle matter with diameters <2.5 μm (PM2.5)
exposure on normal-appearing brain volumes among dementia-free elderly women.
Methods
A total of 1,315 women (age 65–80 years) free of dementia were enrolled in an observational
study between 1996 and 1999 and underwent structural brain MRI in 2005 to 2006. According
to prospectively collected and geocoded participant addresses, we used a spatiotemporal model
to estimate the 3-year average PM2.5 exposure before the MRI. We examined the joint asso-
ciations of baseline LCn3PUFAs in red blood cells (RBCs) and PM2.5 exposure with brain
volumes in generalized linear models.
Results
After adjustment for potential confounders, participants with higher levels of RBC LCn3PUFA
had significantly greater volumes of white matter and hippocampus. For each interquartile
increment (2.02%) in omega-3 index, the average volume was 5.03 cm3 (p < 0.01) greater in the
white matter and 0.08 cm3 (p = 0.03) greater in the hippocampus. The associations with RBC
docosahexaenoic acid and eicosapentaenoic acid levels were similar. Higher LCn3PUFA at-
tenuated the inverse associations between PM2.5 exposure and white matter volumes in the
total brain andmultimodal association areas (frontal, parietal, and temporal; all p for interaction
<0.05), while the associations with other brain regions were not modified. Consistent results
were found for dietary intakes of LCn3PUFAs and nonfried fish.
Conclusions
Findings from this prospective cohort study among elderly women suggest that the benefits of
LCn3PUFAs on brain aging may include the protection against potential adverse effects of air
pollution on white matter volumes.
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Increasing evidence has shown that exposure to ambient fine
particle matter with diameters <2.5 μm (PM2.5) is a novel
environmental risk factor for cognitive decline among the
elderly.1 Previous studies examining the association between
PM2.5 exposure and brain size have reported smaller brain
volumes, especially in normal-appearing white matter, among
cognitively intact elderly people living in locations with higher
levels of long-term PM2.5 exposure.
2,3
Long-chain omega-3 polyunsaturated fatty acids (LCn3PU-
FAs) are important components of synaptic membranes and
play a critical role in maintaining brain structure and function
during aging.4 Through multiple modes of protective
actions,5–8 higher LCn3PUFA levels were associated with
greater total brain volume,9 greater global gray matter10 and
hippocampal volumes,9 and increased integrity of white
matter.11–14 Prompted by the promise of these neurotrophic
effects, many toxicologists have reported that LCn3PUFAs
reduce the brain damage caused by exposures to various en-
vironmental neurotoxins, including lead,15 organic solvents,16
and methylmercury.17 However, no previous studies have ex-
amined whether LCn3PUFAs offer similar protection against
the potential neurotoxic effects of PM2.5 exposure.
Therefore, we investigated whether red blood cell (RBC)
LCn3PUFA levels (RBC docosahexaenoic acid [DHA] +
eicosapentaenoic acid [EPA], or the omega-3 index) modify
the association between PM2.5 exposure and brain structure
using data from the Women’s Health Initiative Memory
Study–Magnetic Resonance Imaging (WHIMS-MRI).
Methods
Study design and population
WHIMS was an ancillary study to the Women’s Health Ini-
tiative (WHI) clinical trials of postmenopausal hormone
therapy. In 1996 to 1999 (henceforth referred to as baseline),
a total of 7,427 women 65 to 80 years of age who were free of
dementia and community dwelling were recruited from 39 of
the WHI clinical centers and 10 satellite sites. The detailed
design and methods of the WHI clinical trials and WHIMS
studies have been published elsewhere.18 A subsample of
1,403 were recruited across 14 WHIMS centers in the con-
tiguous United States to participate in the WHIMS-MRI
study in 2005 to 2006.19 This study included a total of 1,315
participants after the exclusion of 88 participants without valid
omega-3 index measurements. In the secondary analyses of
dietary LCn3PUFA and fish intakes, we excluded 2 with in-
complete dietary data and 30 who reported an implausible
total energy intake (<600 or >5,000 kcal/d) from 1,403
participants inWHIMS-MRI, leaving 1,371 participants in the
analyses.
Standard protocol approvals, registrations,
and patient consents
Approval was received from the ethics standards committee
on human experimentation for all experiments with human
participants. Written informed consent was obtained from all
study participants (consent for research).
Omega-3 index measurements
We analyzed baseline erythrocyte membrane fatty acid com-
position by using gas chromatography with flame ionization
detection and expressed it as a weight percent of total identified
fatty acids.20 The omega-3 index was defined as the sum of
membrane DHA and EPA.21 The intra-assay coefficient of
variation for omega-3 index was 1.6% and 0.8% for the low and
high controls, respectively; the interassay coefficient of varia-
tion was 3.8% and 1.7%.9 During the aliquoting phase, the RBC
samples were stored incorrectly at −20°C for a period of ≈2
weeks, causing oxidative degradation of some of the long chain
omega-6 and omega-3 polyunsaturated fatty acid before mea-
surement. To estimate the original LCn3PUFA levels, a multi-
ple imputation strategy based on new laboratory analyses was
undertaken.20 This technique is well suited to correct bias.20
We used the standard statistical methods recommended in the
WHI to analyze the RBC data. Specifically, we used the SAS
procedure PROC MIANALYZE (SAS Institute, Inc, Cary,
NC), which implements the Rubin technique and calculates
confidence intervals for the overall inference by using the co-
variance matrix and parameter estimates from linear models.20
Assessment of LCn3PUFA intake and
fish consumption
We assessed LCn3PUFA intake and fish consumption at
baseline screening using a semiquantitative food frequency
questionnaire modified from the original National Cancer
Institute and Block food frequency questionnaire.22 Because
frying, especially deep-fat frying, may substantially alter the
fatty acid content of a fish meal,23 fish consumption was di-
vided into fried and nonfried fish groups. Nonfried fish was
the sum of nonfried shellfish, canned tuna, tuna salad, tuna
casserole, and broiled or baked white and dark fish. Nutrient
intakes were estimated from a database derived from the
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(with average Pearson r2 = 0.70).30 This statistically validated
BME model was applied to each geocoded participant address
to generate a yearly time series of PM2.5 exposure and then
combined with participant address histories, including reloca-
tions, to calculate the 3-year moving average PM2.5 as an in-
dicator of long-term exposure.
Other covariates
Participants provided information on demographics, socio-
economic status, lifestyle factors, medial history, and clinical
characteristics through self-administered questionnaires at
baseline. The information included age, race/ethnicity, US
region, education attainment, family income, employment
status, smoking status, alcohol consumption, body mass index
(BMI), physical activity, prior depression, random assignment
to hormone therapy, and medical histories of hypertension,
diabetes mellitus, hypercholesterolemia, and cardiovascular
diseases. BMI (kilograms per meter squared) was calculated as
weight divided by height squared. The presence of prior de-
pressive disorders was examined with the Shortened Center for
Epidemiologic Studies Depression scale using the Diagnostic
Interview Schedule. A value >0.06 was defined as having de-
pression, as defined by the Burnam screening algorithm.31 We
defined hypertension by any self-reported use of antihyper-
tensive medication or elevated blood pressure (systolic blood
pressure≥140mmHgor diastolic blood pressure ≥90mmHg)
32; diabetes mellitus by a physician’s diagnosis and oral medi-
cations or insulin therapy via self-report33; and hypercholes-
terolemia by any self-reported use of antihypercholesterolemic
medication.2 History of cardiovascular diseases included self-
reported previous coronary heart disease (myocardial in-
farction, coronary angioplasty, or coronary artery bypass graft),
stroke, or TIA.2 To measure neighborhood socioeconomic
status (NSES) at baseline, WHI calculated the NSES score.34
This index was composed of (1) median household income;
(2)median value of owner-occupied housing units; (3) percent
of households with interest, dividends, or rent income;
(4) percent of adults >25 years of agewith a high school degree;
(5) percent of adult >25 years of age with a college degree; and
(6) percent of civilian population >16 years of age with pro-
fessional, managerial, or executive occupations.
Statistical analyses
We summarized baseline characteristics and brain volumes of
participants using mean values with SDs for continuous varia-
bles and proportions for categorical variables. Analysis of var-
iance and χ2 test were used to assess differences across quartiles
of the omega-3 index. We used multivariable-adjusted gener-
alized linear regression models to examine the associations
between erythrocyte membrane and dietary levels of
LCn3PUFAs and nonfried fish consumption in relation to
brain volumes, adjusting for intracranial volume, total energy
intake (in the analyses of dietary intakes), age (65–69, 70–74,
or ≥75 years), race/ethnicity (non-Hispanic white, black,
Hispanic/Latino, or others), US regions (Northeast, South,
Midwest, or West), education attainment (less than high
school, high school graduate or equivalents, or college graduate
University of Minnesota’s Nutrition Coordinating Center 
(Minnesota Nutrition Data System for Research, Minneap-
olis). In this study, we defined LCn3PUFA intake as the sum 
of DHA and EPA intakes from diet. Data on supplemental use 
of fish oil were collected, but the frequency of use and dosage 
were not available.
MRI scanning and data processing
This study followed standardized scan acquisition and pro-
cessing protocols, developed by the WHIMS-MRI Quality 
Control Center in compliance with the American College of 
Radiology MRI Quality Control Program, in all centers.24 In 
brief, standard T1-weighted, T2-weighted, proton density–
weighted, and fluid-attenuated inversion recovery scans were 
acquired with 1.5T scanners. Regional volumetric measure-
ments of gray matter, white matter, and CSF were subsequently 
obtained by the use of a validated, automated computer-based 
template warping method.25 We summed the numbers of 
voxels in gray matter, white matter, and CSF to calculate vol-
umes of each labeled brain region. Intracranial volume was 
estimated as the total cerebral hemispheric volumes, including 
ventricular CSF and the CSF within the sulcal spaces. To 
segment small vessel ischemic diseases (SVIDs), a brain lesion 
segmentation algorithm was applied to T1, T2, and fluid-
attenuated inversion recovery images.26,27 By combining the 
tissue segmentation and lesion segmentation algorithm, we 
classified every voxel as normal (not SVID affected) or ab-
normal (SVID affected), allowing calculation of normal-
appearing brain volumes and SVID volumes in each region. 
Volumes of gray and white matter reported in the present study 
referred to normal-appearing brain tissue only. At the associa-
tion cortices, including frontal, parietal, occipital, and temporal 
lobes, we focused on frontal, parietal, and temporal lobes that 
are critical to memory and complex cognitive processing.
Estimation of PM2.5 exposure
WHIMS-MRI participant addresses, collected prospectively at 
each clinic visit and updated at least biannually, were geocoded 
following a standardized protocol.28 Using the bayesian maxi-
mum entropy (BME)–based spatiotemporal modeling 
method,29,30 we modeled the daily ambient concentration of 
PM2.5 across the nation from 1999 to 2005 to 2006, when the 
MRI scans were performed. We could not estimate PM2.5 ex-
posure before 1999 due to the limited monitoring data. By 
integrating nationwide monitoring data from the US Environ-
mental Protection Agency Air Quality System (AQS) and the 
output of chemical transport models, this BME method char-
acterizes spatiotemporal interdependence of environmental 
data to estimate mean trends and covariance of the air pollution 
fields over space and time. To assess the estimation accuracy of 
the BME model, we performed a 10-fold estimation analysis, 
with the AQS monitoring stations evenly divided in 10 distinct 
sets. For each fold, we implemented the BME estimation to 
obtain the daily estimates using only the data from the 
remaining 90% of the monitoring stations. The empirical data 
showed that the resulting BME estimates of daily PM2.5 expo-
sures correlated well with the AQS-recorded concentrations
or higher degree), family income (<$10,000, $10,000–$34,900,
$35,000–$74,900, ≥75,000 [US dollars], or do not know),
smoking status (never, former, or current smokers), alcohol
consumption (never, former, current drinkers <1 drink per day,
or current drinkers ≥1 drink per day), BMI (<25.0, 25.0–29.9,
or ≥30.0 kg/m2), moderate or strenuous activity ≥20 min/day
(none, some activity, 2–4 episodes per week, or >4 episodes per
week), random assignment to hormone therapy (estrogen
alone or estrogen + progesterone), and medical histories (hy-
pertension, diabetes mellitus, hypercholesterolemia, and car-
diovascular diseases; yes or no).
The associations between PM2.5 exposure and brain volumes
were assessed in generalized linear regression model, stratified
by erythrocyte membrane and dietary levels of LCn3PUFAs,
DHA, and EPA and by nonfried fish consumption. We pre-
sented the linear regression coefficients per interquartile in-
crease (3.22 μg/m3) in the continuous variable of PM2.5
exposure. We tested interactions using the continuous vari-
able of PM2.5 exposure and the dichotomous (less than me-
dian vs median or greater) nutritional variables (erythrocyte
membrane and dietary levels of LCn3PUFAs, nonfried fish
consumption). In a sensitivity analysis, the Benjamini-
Hochberg procedure was used to control type 1 error
across the multiple interaction tests.35
To test the robustness of the findings, several sensitivity
analyses were performed. First, we also adjusted for the
modified Mini-Mental State Examination score at baseline or
excluded participants who had developed dementia or cog-
nitive decline before MRI scans to evaluate the possibility of
biases resulting from self-selection among participants with
better brain health at baseline. Second, to explore whether
SVID could affect the observed associations, we in addition
adjusted the models for SVID volume in the corresponding
brain region. Third, because stroke and TIA may alter brain
MRI measures independently of PM2.5 exposure or omega-3
index levels, we excluded elderly women who experienced
these incident events before the MRI scans. Similarly, com-
mon rheumatologic/demyelinating diseases such as multiple
sclerosis, major depression, and bipolar disorder may affect
brain structure36–38; thus, participants who reported these
diseases at baseline were excluded. Forth, because socioeco-
nomic status may be an important confounder for the asso-
ciation between air pollution and brain aging, we further
adjusted for NSES score when examining the effect mod-
ifications. Fifth, we further adjusted for supplemental use of
fish oil in the analyses of dietary LCn3PUFA intake. Finally,
because intracranial volume is the sum of the total hemi-
spheric volume and 2 compartments of CSF, 2 methods are
accepted to control for intracranial volume: (1) include in-
tracranial volume as a covariate in models or (2) divide
hemispheric volume by intracranial volume and use this var-
iable as the outcome. We used the first method in our main
analyses and the second one as a sensitivity analysis. All
analyses were performed with SAS version 9.4. A 2-sided value
of p ≤ 0.05 was considered statistically significant.
Data availability
The data-sharing plan ofWHIMS-MRI study is consistent with
the policy of National Heart, Lung, and Blood Institute, NIH,
and US Department of Health and Human Services. Any data
not published within this article are available in WHIMS-MRI
data repository. Anonymized data may be shared by request
from any qualified investigator in compliance with the regu-
lations of National Heart, Lung, and Blood Institute, NIH, and
US Department of Health and Human Services.
Results
In the study population, 91% of participants were non-
Hispanic whites with an average age of 70 years at baseline.
Participants with higher levels of the omega-3 index were less
likely to be non-Hispanic white. More detailed baseline
characteristics of participants are summarized in table 1.
Participants with higher levels of the omega-3 index had
higher intakes of LCn3PUFAs, DHA, EPA, and nonfried
fish. In the univariate model, participants in the highest
omega-3 index quartile, compared to those with lower
omega-3 index, had the largest normal-appearing white
matter volume (WMV), and this pattern was observed in the
WMV of the frontal lobe, parietal lobe, temporal lobe, and
corpus callosum (table 2). Participants with higher omega-3
index also had larger hippocampal volumes (table 2).
However, no statistically significant differences were ob-
served across omega-3 index quartiles in the volumes of
cortical gray matter, basal ganglia, or ventricular size
(table 2).
Results of multiple linear regression models are summarized
in tables 3 and 4. Participants with higher omega-3 index
levels had significantly greater volumes in the total associa-
tion brain, white matter, and hippocampus after adjustment
for potential confounders, similar to a previous report in the
WHIMS-MRI cohort.9 In addition, a higher omega-3 index
was consistently associated with greater volumes of regional
WMV, including the frontal lobe, parietal lobe, temporal
lobe, and corpus callosum. The associations with erythrocyte
membrane DHA and EPA levels were similar. The observed
associations were not changed materially in any sensitivity
analysis, including the one with additional adjustment for
SVID. However, no association with cortical gray matter of
association brain areas, basal ganglia, or ventricular volumes
was observed for the omega-3 index in the multiple linear
regression.
Elderly women living in locations with higher ambient PM2.5
exposure had significantly smaller WMV (data not shown), as
shown in a previous report that also found no apparent expo-
sure effects on cortical gray matter and hippocampal volumes.2
The putatively neurotoxic effect of PM2.5 on WMV was at-
tenuated by the omega-3 index (figure 1). Among women with
higher omega-3 index levels (above the median level 5.01%),
the observed inverse association between PM2.5 exposure and
Table 1 Baseline characteristics of the study population among quartiles of RBC omega-3 index (n = 1,315)a,b
Quartiles of the omega-3 index (%)
Total p ValueQ1 (<4.12) Q2 (4.12–5.01) Q3 (5.01–6.14) Q4 (≥6.14)
Omega-3 index, % 3.43 ± 0.13 4.57 ± 0.19 5.53 ± 0.23 7.45 ± 0.28 5.25 ± 0.21 —
Demographics
Age, % 0.430
65–69 y 27.3 24.2 23.7 24.7 50.2
70–74 y 21.3 26.5 26.8 25.4 35.7
≥75 y 25.7 24.1 25.0 25.2 14.1
Race/ethnicity, % <0.001
Non-Hispanic white 26.2 25.8 25.1 22.8 90.8
Black 8.6 12.7 28.6 50.0 4.6
Hispanic white 31.2 26.4 18.2 24.2 1.6
Other or missing 7.5 19.1 19.8 53.6 3.0
US region, % <0.001
Northeast 17.2 18.9 24.7 39.2 23.8
South 21.6 28.2 28.8 21.4 15.3
Midwest 34.6 29.6 23.3 12.5 34.0
West 21.5 22.9 25.3 30.3 26.9
Socioeconomic status
Education, % 0.075
Less than high school 25.4 28.1 24.5 22.1 4.4
High school graduate or equivalents 31.0 28.7 23.1 17.2 23.7
College graduate or higher degree 23.0 23.6 25.6 27.7 71.9
Family income, % <0.001
<$10,000 33.7 25.0 22.3 18.9 3.7
$10,000–$34,999 29.9 27.4 25.2 17.5 48.1
$35,000–$74,999 20.4 24.0 24.6 31.0 35.5
≥$75,000 14.8 17.3 24.3 43.6 9.5
Do not know 21.1 23.3 32.8 22.8 3.3
Employment, % 0.797
Currently employed 27.9 23.3 25.4 23.4 18.2
Currently not employed 27.3 25.3 19.9 27.6 10.7
Retired 23.8 25.5 25.7 25.1 71.1
Lifestyle factors
Smoking status, % 0.059
Never 26.3 26.5 24.5 22.7 58.4
Former 21.4 22.9 27.1 28.7 37.5
Current 39.6 23.9 12.3 24.2 4.1
Alcohol consumption, % 0.075
Continued
WMV were non-remarkable and statistically non-significant in
the total brain and the multi-modal association areas. In con-
trast, the inverse associations were stronger and remained
statistically significant in women with lower levels of omega-3
index. Similar modifications were observed for levels of both
DHA and EPA. Tests for interaction were generally consistent
with or without accounting for multiple comparison, and the
findings remained in all sensitivity analyses (data not shown).
Table 1 Baseline characteristics of the study population among quartiles of RBC omega-3 index (n = 1,315)a,b (continued)
Quartiles of the omega-3 index (%)
Total p ValueQ1 (<4.12) Q2 (4.12–5.01) Q3 (5.01–6.14) Q4 (≥6.14)
Never 30.8 25.5 22.3 21.5 12.8
Former 28.1 26.0 26.7 19.2 16.4
Current <1 drink/d 24.5 24.9 25.1 25.5 59.3
Current ≥1 drink/d 16.1 23.0 26.3 34.6 11.5
BMI, % 0.035
<25.0 kg/m2 22.8 21.0 24.3 31.9 30.7
25.0–29.9 kg/m2 24.7 26.2 26.1 23.0 37.9
≥30.0 kg/m2 27.4 27.3 24.6 20.8 31.4
Moderate or strenuous activities ≥20 min/d, % 0.047
No activity 28.7 25.8 23.7 21.8 56.3
Some activity 23.6 27.0 22.7 26.7 5.3
2–4 episodes/wk 20.5 24.0 27.7 27.8 20.4
≥4 episodes/wk 18.6 23.2 26.7 31.5 18.1
Clinical characteristics
Depression (yes), % 26.6 26.2 20.8 26.4 8.0 0.999
Random assignment to HT, % 0.585
Estrogen-alone intervention 24.6 26.7 25.6 23.1 18.2
Estrogen-alone control 28.1 26.3 24.9 20.7 18.6
Estrogen + progesterone intervention 25.4 25.3 25.0 24.3 31.1
Estrogen + progesterone control 22.9 23.1 24.8 29.3 32.1
Hypertension (yes), % 25.2 24.7 23.9 26.2 36.2 0.778
Diabetes mellitus (yes), % 26.2 25.8 25.1 22.9 3.2 0.995
Hypercholesterolemia (yes), % 21.7 22.6 27.1 28.5 16.1 0.444
Cardiovascular disease (yes), % 25.5 25.6 24.0 24.9 14.0 0.823
Intakes of LCn3PUFAs and fish
LCn3PUFAs, mg/d 59.93 ± 3.46 81.87 ± 5.03 108.66 ± 7.08 178.10 ± 8.31 107.20 ± 2.93 <0.001
DHA, mg/d 39.37 ± 2.20 53.76 ± 3.32 71.65 ± 4.73 121.27 ± 5.83 71.55 ± 2.01 <0.001
EPA, mg/d 20.55 ± 1.32 28.11 ± 1.79 37.01 ± 2.45 56.83 ± 2.64 35.65 ± 0.96 <0.001
Nonfried fish, servings/d 0.05 ± 0.005 0.08 ± 0.007 0.11 ± 0.01 0.20 ± 0.01 0.11 ± 0.004 <0.001
PM2.5 exposure
3-y moving average PM2.5 exposure, μg/m
3 11.66 ± 0.17 11.56 ± 0.15 11.66 ± 0.16 12.30 ± 0.15 11.80 ± 0.07 0.005
Abbreviations: BMI = body mass index; HT = hormone therapy; LCn3PUFA = long chain omega-3 polyunsaturated fatty acids; PM2.5 = particle matter with
diameters <2.5 μm; Q = quartile; RBC = red blood cell.
a Results are presented bymeans ± SDs or proportions (row proportions across quartiles of the omega-3 index and column proportions for the total sample).
b p Values are for any differences across quartiles of the omega-3 index using analysis of variance or χ2 test, as appropriate.
The modifications by the omega-3 index were limited to the
normal-appearing association WMV, with no statistically sig-
nificant differences observed in the corpus callosum, cortical
gray matter, hippocampus, or ventricle volume.
In the secondary analyses, we examined whether dietary
intakes of LCn3PUFAs and nonfried fish had similar associ-
ations with WMV (table 5) and modified the observed as-
sociation of PM2.5 on WMV (figure 2). Participants with
Table 2 Distribution of brain volumes in relation to quartiles of RBC omega-3 indexa,b
MRI-measured brain volume
Quartiles of the omega-3 index
p ValueQ1 (<4.12%), cm3 Q2 (4.12%–5.01%), cm3 Q3 (5.01%–6.14%), cm3 Q4 (≥6.14%), cm3
Total brain volume 1,087.15 ± 6.22 1,093.37 ± 7.84 1,090.63 ± 8.99 1,087.02 ± 6.77 0.907
Normal brain volume 1,078.34 ± 6.12 1,084.23 ± 7.64 1,080.96 ± 9.00 1,078.38 ± 6.81 0.979
Association brain 717.39 ± 4.22 723.03 ± 4.55 721.65 ± 5.73 720.95 ± 4.86 0.362
Total white matter 402.68 ± 3.23 407.41 ± 3.64 407.20 ± 4.41 410.15 ± 3.44 0.038
Frontal lobe 156.85 ± 1.40 158.67 ± 1.52 158.52 ± 1.83 160.44 ± 1.47 0.033
Parietal lobe 85.76 ± 0.83 86.47 ± 0.89 86.59 ± 1.17 87.89 ± 0.90 0.042
Temporal lobe 93.16 ± 0.80 94.30 ± 0.93 94.37 ± 0.92 94.96 ± 0.78 0.026
Corpus callosum 8.86 ± 0.08 8.96 ± 0.09 9.01 ± 0.10 9.06 ± 0.08 0.023
Total gray matter 394.27 ± 2.90 396.06 ± 2.87 395.55 ± 2.93 392.55 ± 3.17 0.684
Frontal lobe 118.64 ± 1.02 119.10 ± 1.09 118.54 ± 0.99 116.74 ± 1.14 0.179
Parietal lobe 62.64 ± 0.59 62.61 ± 0.64 62.15 ± 0.65 61.19 ± 0.69 0.063
Temporal lobe 82.05 ± 0.67 82.25 ± 0.63 82.04 ± 0.74 81.17 ± 0.75 0.348
Hippocampus 5.61 ± 0.07 5.69 ± 0.07 5.79 ± 0.07 5.79 ± 0.06 0.016
Basal ganglia 34.71 ± 0.22 34.97 ± 0.20 35.05 ± 0.22 34.94 ± 0.22 0.395
Ventricle 36.93 ± 1.16 36.46 ± 1.15 36.36 ± 1.13 37.60 ± 1.10 0.640
Abbreviations: Q = quartile; RBC = red blood cell.
a Brain volumes (not divided by intracranial volume) are presented as means ± SDs.
b p Values are for any differences across quartiles of the omega-3 index using analysis of variance test with the adjustment for intracranial volume.














Adjusted β ± SE 1.70 ± 4.09 0.33 ± 0.47 3.90 ± 1.64 5.03 ± 1.61 −0.49 ± 1.52 0.08 ± 0.04 0.04 ± 0.13 0.09 ± 0.61
p Value 0.678 0.476 0.018 0.002 0.747 0.028 0.751 0.885
RBC DHA, %
Adjusted β ± SE 0.92 ± 4.32 0.31 ± 0.48 3.74 ± 1.72 4.69 ± 1.66 −0.33 ± 1.61 0.09 ± 0.04 0.03 ± 0.13 −0.06 ± 0.65
p Value 0.832 0.514 0.031 0.005 0.838 0.024 0.839 0.921
RBC EPA, %
Adjusted β ± SE 3.22 ± 3.15 0.23 ± 0.39 2.59 ± 1.18 3.74 ± 1.29 −0.74 ± 1.17 0.03 ± 0.03 0.06 ± 0.10 0.50 ± 0.48
p Value 0.307 0.550 0.028 0.004 0.528 0.346 0.579 0.306
Abbreviations: DHA = docosahexaenoic acid; EPA = eicosapentaenoic acid; RBC = red blood cell.
a All models were constructed using multiple linear regression model with adjustment for intracranial volume, age, race/ethnicity, US regions, education
attainment, family income, smoking status, alcohol consumption, body mass index, moderate or strenuous activity ≥20 min/d, random assignment to
hormone therapy, and medical histories (hypertension, diabetes mellitus, hypercholesterolemia, and cardiovascular diseases).
b The associations are expressed as the linear regression coefficients ± standard errors per interquartile increment in the continuous variables of the omega-3
index, DHA and EPA. The interquartile ranges of the omega-3 index, DHA, and EPA were 2.02%, 1.80%, and 0.37%, respectively.
higher dietary intake of LCn3PUFAs (per interquartile in-
crement 104.25 mg/d) had significantly greater WMV after
adjustment for potential confounders. Higher nonfried fish
consumption (per interquartile increment of 0.14 servings per
day) was also associated with a greater WMV in the temporal
lobe. Similar to the observed effect modification using
LCn3PUFA biomarker data, the potential neurotoxic effect of
PM2.5 exposure on WMV also was modified by the dietary
intakes of LCn3PUFAs and nonfried fish. Higher levels (above
the median level) of LCn3PUFA, DHA, EPA, or nonfried fish
intake significantly attenuated the inverse associations between
PM2.5 and WMV in the total brain and the multimodal asso-
ciation areas, with much stronger adverse effects of PM2.5 ob-
served in elderly women with lower levels of intakes. The effect
modifications persisted in all the sensitivity analyses (data not
shown). The intakes of LCn3PUFAs and nonfried fish did not
modify the associations between PM2.5 and the volumes of the
corpus callosum, cortical gray matter, hippocampus, or
ventricle.
Discussion
In this prospective cohort study, we found that higher eryth-
rocyte EPA + DHA levels (i.e., the omega-3 index) attenuated
the inverse association between PM2.5 exposure and WMV
measured by brain MRI in elderly women. Similar patterns of
modification by dietary intakes of LCn3PUFAs and nonfried
fish were observed as expected owing to the documented val-
idity of the omega-3 index as an intake biomarker.
Our study adds to the growing evidence that LCn3PUFAs may
contribute to the healthy aging of white matter. The benefits of
LCn3PUFAs on brain atrophy have been demonstrated in
epidemiologic studies. For example, studies of dementia-free
elderly participants found that nutrient intake patterns related
to higher blood LCn3PUFA levels were associated with lower
white matter hyperintensity volumes.11–14,39 Similarly, a higher
intake of nonfried fish was associated with fewer white matter
abnormalities in a large prospective study of healthy elderly
participants.13 In our sensitivity analyses, the associations be-
tween the omega-3 index and normal-appearing WMV were
independent of SVID volume (data not shown), and very
similar associations were found in elderly women who
remained cognitively intact without dementia or stroke. These
interesting findings suggest that the neurotrophic effects of
LCn3PUFAs observed in this study might take place in the
preclinical stage before overt neurodegeneration or cerebro-
vascular disease. LCn3PUFAs have been reported to directly
protect oligodendrocytes, the cells responsible for the pro-
duction and maintenance of myelin, against excitatory cell
death.6 They also induce M2 (alternatively activated macro-
phages) polarization in cultured microglia,5 which can resolve
local inflammation and promote remyelination in the white
matter, thereby facilitating white matter repair.40 EPA has also
been found to stimulate the expression of specific myelin
proteins through decreased levels of cAMP-response element-
binding protein phosphorylation.41
An increasing number of studies have suggested that white
matter architecture may represent a novel target of airborne
particle–induced neurotoxicity. Evidence from both laboratory
animals42 and humans2,43 suggests that long-term exposure to
ambient air particles may result in smaller WMVs, which may
be attributable to their effects on myelin loss or chronic
microglial activation. In mouse models, decreased myelin basic
protein and increased Iba1 immunostaining, a marker for
microglial activation, were induced by exposure to ambient fine
Table 4 Multiple linear regression of brain WMVs against RBC omega-3 indexa,b
Association WMV Frontal lobe WMV Parietal lobe WMV Temporal lobe WMV Corpus callosum
Omega-3 index, %
Adjusted β ± SE 5.07 ± 1.59 2.16 ± 0.74 1.19 ± 0.45 1.35 ± 0.39 0.12 ± 0.05
p Value 0.002 0.004 0.009 <0.001 0.012
RBC DHA, %
Adjusted β ± SE 4.71 ± 1.64 2.02 ± 0.75 1.14 ± 0.48 1.25 ± 0.40 0.11 ± 0.05
p Value 0.004 0.008 0.018 0.002 0.019
RBC EPA, %
Adjusted β ± SE 3.79 ± 1.28 1.59 ± 0.60 0.79 ± 0.35 1.03 ± 0.33 0.07 ± 0.04
p Value 0.003 0.008 0.025 0.002 0.039
Abbreviations: DHA = docosahexaenoic acid; EPA = eicosapentaenoic acid; RBC = red blood cell; WMV = white matter volume.
a All models were constructed using multiple linear regression model with adjustment for intracranial volume, age, race/ethnicity, US regions, education
attainment, family income, smoking status, alcohol consumption, body mass index, moderate or strenuous activity ≥20 minutes, random assignment to
hormone therapy, and medical histories (hypertension, diabetes mellitus, hypercholesterolemia, and cardiovascular diseases).
b The associations are expressed as the linear regression coefficients ± standard errors per interquartile increment in the continuous variables of the omega-3
index, DHA and EPA. The interquartile ranges of the omega-3 index, DHA, and EPA were 2.02%, 1.80%, and 0.37%, respectively.
Figure 1 Associations between PM2.5 exposure and brain normal-appearing WMVs stratified by RBC omega-3 index
All models (A–C) were constructed by using linear regression model with adjustment for intracranial volume, age, race/ethnicity, US regions, education
attainment, family income, employment, smoking status, alcohol consumption, body mass index, moderate or strenuous activity ≥20 min/d, prior de-
pression, random assignment to hormone therapy, and medical histories (hypertension, diabetes mellitus, hypercholesterolemia, and cardiovascular
diseases). Associations are expressed as the linear regression coefficients per interquartile (3.22 μg/m3) increment in the continuous variable of 3-year
moving average particlematter with diameters <2.5μm (PM2.5) exposure before theMRI examination. For example, in panel A, for each interquartile increase
in PM2.5 exposure, the averagewhitematter volume (WMV) was 11.52 cm
3 smaller among participants with lower omega-3 index (less thanmedian level) and
0.12 cm3 smaller among participants with higher omega-3 index (median level or greater). DHA = docosahexaenoic acid; EPA = eicosapentaenoic acid; RBC =
red blood cell. Significance of p values: *p < 0.05, **p < 0.001, ***p < 0.0001.
particle matter.44 Because high levels of LCn3PUFAs may al-
leviate myelin damage and the subsequent white matter ab-
normalities, LCn3PUFAs may counteract the potential
neurotoxicity of PM2.5 on white matter. In this study on older
women, there was no appreciable adverse PM2.5 effect on
WMV among participants with higher omega-3 index levels.
We also found that the negative association between PM2.5 and
WMV was similarly attenuated by higher RBC DHA and EPA
levels and by greater dietary intakes of LCn3PUFAs and
nonfried fish consumption. Future laboratory studies may
elucidate the underlying mechanisms (e.g., anti-inflammatory
effects45), and clinical trials with LCn3PUFA supplementation
may demonstrate the potential influences of LCn3PUFA intake
as one of the critical strategies for preventing PM2.5-induced
neurotoxicity.
Some limitations of the present study need to be acknowl-
edged. First, the multiple imputation method used to correct
for the oxidative degradation of RBC fatty acids, although well
suited for this purpose, increased the total variability in the
imputed data and would therefore cause the reported associa-
tions and effect modifications to be underestimated.20 There-
fore, the true association and effect modification of LCn3PUFA
status with WMV would be even stronger than what was seen
in this study. Second, the present study included only elderly
women; thus, our findings could not be generalized tomen and
younger women. However, the neurotrophic effects of
LCn3PUFAs do not appear to be different by sex or age
according to the literature.46 Third, the present study focused
on PM2.5 as a regional pollutant, and we did not characterize
the sources of PM2.5. Fourth, the spatiotemporal models
allowed estimates of only late-life exposure to PM2.5 after 1999.
Because air pollution levels have declined over the last few
decades, exposure to PM2.5 during midlife or earlier life may
impart a greater risk for accelerated aging of white matter,
which should be investigated in future studies. Currently, to the
best of our knowledge, no existing cohort has PM2.5 data
available before 1999. Finally, according to a previous report in
WHIMS-MRI, women who voluntarily provided MRI scans
might vary by demographic and clinical characteristics, similar
to other observational studies.19 Thus, we could not completely
rule out the possibility of survival bias.
Our study had major strengths. First, analyses of LCn3PUFA
status were based on RBC membrane fatty acid composition
and dietary intake, both of which showed consistent evidence
of effect modification. These complementary measures have
different strengths, limitations, and sources of errors. The use of
both biomarkers and dietary estimates provides a comprehen-
sive evaluation of the effect modification of interest, supporting
the neurologic benefits of LCn3PUFAs on brain volumetric
measures. Second, the long-termPM2.5 exposure was estimated
with longitudinal geocoded participant addresses reflecting
changes in address over time.














Adjusted β ± SE 2.38 ± 1.14 2.43 ± 1.13 1.07 ± 0.52 0.55 ± 0.32 0.74 ± 0.29 0.07 ± 0.03
p Value 0.038 0.031 0.041 0.087 0.010 0.034
DHA intake, mg/d
Adjusted β ± SE 2.67 ± 1.06 2.74 ± 1.04 1.20 ± 0.48 0.64 ± 0.30 0.77 ± 0.26 0.06 ± 0.03
p Value 0.011 0.009 0.013 0.032 0.003 0.033
EPA intake, mg/d
Adjusted β ± SE 1.26 ± 1.23 1.27 ± 1.22 0.57 ± 0.56 0.25 ± 0.35 0.52 ± 0.31 0.07 ± 0.03
p Value 0.308 0.297 0.315 0.478 0.088 0.049
Nonfried fish intake,
servings/d
Adjusted β ± SE 1.72 ± 1.11 1.75 ± 1.09 0.77 ± 0.51 0.35 ± 0.31 0.59 ± 0.28 0.06 ± 0.03
p Value 0.122 0.111 0.132 0.262 0.034 0.056
Abbreviations: DHA = docosahexaenoic acid; EPA = eicosapentaenoic acid; LCn3PUFA = long chain omega-3 polyunsaturated fatty acids; WMV =whitematter
volume.
a All models were constructed using linear regression model with adjustment for intracranial volume, total energy intake, age, race/ethnicity, US regions,
education attainment, family income, smoking status, alcohol consumption, body mass index, moderate or strenuous activity ≥20 min/day, random as-
signment to hormone therapy, and medical histories (hypertension, diabetes mellitus, hypercholesterolemia, and cardiovascular diseases).
b The association is expressed as the linear regression coefficients ± standard errors per interquartile increment in the continuous variables of LCn3PUFA and
nonfried fish intakes. The interquartile ranges of total LCn3PUFA, DHA, EPA, and nonfried fish intakes are 104.25 mg/d, 66.08 mg/d, 37.33 mg/d, and 0.14
servings per day, respectively.
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Figure 2 Associations between PM2.5 exposure and brain normal-appearingWMVs stratified by intakes of LCn3PUFAs and
nonfried fish
All models (A–D) were constructed using linear regression models with the adjustment for intracranial volume, age, race/ethnicity, US regions,
education attainment, family income, employment, smoking status, alcohol consumption, body mass index, moderate or strenuous activity ≥20 min/
d, prior depression, random assignment to hormone therapy, and medical histories (hypertension, diabetes mellitus, hypercholesterolemia, and
cardiovascular diseases). Associations are expressed as the linear regression coefficients per interquartile (3.22 μg/m3) increment in the continuous
variable of particle matter with diameters <2.5 μm (PM2.5) exposure before the MRI examination. For example, in panel A, for each interquartile
increase in PM2.5 exposure, the average white matter volume (WMV) was 11.92 cm
3 smaller among participants with lower long chain omega-3
polyunsaturated fatty acid (LCn3PUFA) intake (less than median level) and 0.59 cm3 greater among participants with higher LCn3PUFA intake (median
level or greater). DHA = docosahexaenoic acid; EPA = eicosapentaenoic acid. Significance of p values (main and interaction): *p < 0.05, **p < 0.001,
***p < 0.0001.
Findings from this prospective cohort study among elderly 
women suggest that higher LCn3PUFA intake (and thus 
blood levels) could help preserve WMV with aging and pro-
tect against the potential neurotoxic effects of PM2.5 exposure.
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